Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

[Effectiveness of lifestyle intervention program in persons with obesity treated in a day hospital].

Carral San Laureano F, Cabo Navarro D, Ayala Ortega C, Gómez Rodríguez F, Piñero Zaldivar A, Prieto Ferrón M, Jiménez Millán AI, Sanz Sanz A, García Calzado C.

Rev Calid Asist. 2013 Sep-Oct;28(5):285-90. doi: 10.1016/j.cali.2013.03.007. Epub 2013 May 15. Spanish.

PMID:
23684047
2.

Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification.

Poston WS, Reeves RS, Haddock CK, Stormer S, Balasubramanyam A, Satterwhite O, Taylor JE, Foreyt JP.

Int J Obes Relat Metab Disord. 2003 Dec;27(12):1486-93.

PMID:
14634679
3.

Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.

Digenio AG, Mancuso JP, Gerber RA, Dvorak RV.

Ann Intern Med. 2009 Feb 17;150(4):255-62.

PMID:
19221377
4.

Childhood obesity: concept, feasibility, and interim results of a local group-based, long-term treatment program.

Weigel C, Kokocinski K, Lederer P, Dötsch J, Rascher W, Knerr I.

J Nutr Educ Behav. 2008 Nov-Dec;40(6):369-73. doi: 10.1016/j.jneb.2007.07.009.

PMID:
18984493
5.

The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial.

Mutsaerts MA, Groen H, ter Bogt NC, Bolster JH, Land JA, Bemelmans WJ, Kuchenbecker WK, Hompes PG, Macklon NS, Stolk RP, van der Veen F, Maas JW, Klijn NF, Kaaijk EM, Oosterhuis GJ, Bouckaert PX, Schierbeek JM, van Kasteren YM, Nap AW, Broekmans FJ, Brinkhuis EA, Koks CA, Burggraaff JM, Blankhart AS, Perquin DA, Gerards MH, Mulder RJ, Gondrie ET, Mol BW, Hoek A.

BMC Womens Health. 2010 Jun 25;10:22. doi: 10.1186/1472-6874-10-22.

6.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.

7.

Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.

MacLaughlin HL, Cook SA, Kariyawasam D, Roseke M, van Niekerk M, Macdougall IC.

Am J Kidney Dis. 2010 Jan;55(1):69-76. doi: 10.1053/j.ajkd.2009.09.011. Epub 2009 Nov 17.

PMID:
19926371
8.

[GP's intervention in changing lifestyle behavior of adipose patients].

Lazić D, Cikac T, Ozvacić Z, Cop R.

Acta Med Croatica. 2007 Feb;61(1):7-11. Croatian.

PMID:
17593634
9.

Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.

PMID:
17680902
10.

Effects of lifestyle modification on adipocytokine levels in obese patients.

De Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, Perez Castrillon JL.

Eur Rev Med Pharmacol Sci. 2008 Jan-Feb;12(1):33-9.

PMID:
18401970
11.

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.

Diabetes Obes Metab. 2005 Nov;7(6):699-708.

PMID:
16219013
12.

Obesity management in liver clinics: translation of research into clinical practice.

Osland EJ, Powell EE, Banks M, Jonsson JR, Hickman IJ.

J Gastroenterol Hepatol. 2007 Apr;22(4):504-9.

PMID:
17376041
13.

Intensive lifestyle intervention combined with the choice of pharmacotherapy improves weight loss and cardiac risk factors in the obese.

Frost G, Lyons F, Bovill-Taylor C, Carter L, Stuttard J, Dornhorst A.

J Hum Nutr Diet. 2002 Aug;15(4):287-95; quiz 297-9.

PMID:
12153502
14.

Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women.

Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A, Bain CE, Wang CY, Blackburn GL, McTiernan A.

Obesity (Silver Spring). 2012 Aug;20(8):1628-38. doi: 10.1038/oby.2011.76. Epub 2011 Apr 14.

15.

Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects.

de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R.

Ann Nutr Metab. 2006;50(4):354-60. Epub 2006 Jun 28.

PMID:
16809903
16.

Variables predictive of adherence to diet and physical activity recommendations in the treatment of obesity and overweight, in a group of Spanish subjects.

Bautista-Castaño I, Molina-Cabrillana J, Montoya-Alonso JA, Serra-Majem L.

Int J Obes Relat Metab Disord. 2004 May;28(5):697-705.

PMID:
14993911
17.

A randomised control trial comparing lifestyle groups, individual counselling and written information in the management of weight and health outcomes over 12 months.

Ash S, Reeves M, Bauer J, Dover T, Vivanti A, Leong C, O'Moore Sullivan T, Capra S.

Int J Obes (Lond). 2006 Oct;30(10):1557-64. Epub 2006 Mar 14.

PMID:
16534529
18.

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.

PMID:
11220553
19.

Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.

Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M; Kuopio Sleep Apnea Group.

Am J Respir Crit Care Med. 2009 Feb 15;179(4):320-7. doi: 10.1164/rccm.200805-669OC. Epub 2008 Nov 14.

PMID:
19011153
20.

LONG-TERM, SUSTAINED, LIFESTYLE-INDUCED WEIGHT LOSS IN SEVERE OBESITY: THE GET-ReAL PROGRAM.

Shadid S, Jakob RC, Jensen MD.

Endocr Pract. 2015 Apr;21(4):330-8. doi: 10.4158/EP14381.OR.

PMID:
25932566

Supplemental Content

Support Center